ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Cooperative Groups Won’t Get Grants For Head & Neck Cancer, Must Compete For Contract Awards

July 1, 1977

AHCPR Funds Centers to Review Practice

July 4, 1997